Log in
Enquire now

List of Intellipharmaceutics International patents

List of Intellipharmaceutics International patents
List of Southern Research Institute patents
List of DISHCRAFT ROBOTICS, INC. patents
List of BioSig Technologies, Inc. patents
List of companies in Starting Line (venture capital firm)'s investment portfolio
List of SBIR/STTR awards granted to BIOTECHNICAL COMMUNICATIONS, INC.
Patents where
Current Assignee
Name
is
Intellipharmaceutics InternationalIntellipharmaceutics International
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9636306 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient

Patent 9636306 was granted and assigned to Intellipharmaceutics International on May, 2017 by the United States Patent and Trademark Office.

Intellipharmaceutics International
Intellipharmaceutics International
United States Patent and Trademark Office
United States Patent and Trademark Office
9636306
May 2, 2017
‌
US Patent 10293046 Compositions and methods for reducing overdose

Patent 10293046 was granted and assigned to Intellipharmaceutics International on May, 2019 by the United States Patent and Trademark Office.

Intellipharmaceutics International
Intellipharmaceutics International
United States Patent and Trademark Office
United States Patent and Trademark Office
10293046
May 21, 2019
‌
US Patent 10632205 Pharmaceutical composition having reduced abuse potential

Intellipharmaceutics International
Intellipharmaceutics International
Intellipharmaceutics International
Intellipharmaceutics International
United States Patent and Trademark Office
United States Patent and Trademark Office
10632205
April 28, 2020
‌
US Patent 10653776 Compositions and methods for reducing overdose

Intellipharmaceutics International
Intellipharmaceutics International
United States Patent and Trademark Office
United States Patent and Trademark Office
10653776
May 19, 2020
‌
US Patent 10624858 Controlled release composition using transition coating, and method of preparing same

Intellipharmaceutics International
Intellipharmaceutics International
United States Patent and Trademark Office
United States Patent and Trademark Office
10624858
April 21, 2020
‌
US Patent 10064828 Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems

Patent 10064828 was granted and assigned to Intellipharmaceutics International on September, 2018 by the United States Patent and Trademark Office.

Intellipharmaceutics International
Intellipharmaceutics International
United States Patent and Trademark Office
United States Patent and Trademark Office
10064828
September 4, 2018
6 results
0 selected
6 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us